MedGenome US is now rebranded as Signios Bio – same team, renewed identity. Click Here

Pushing the Boundaries of Traumatic Brain Injury Research with Single-Cell and Spatial Transcriptomics

March 28, 2025

Social Share

By Courtney Nirenberchik, Marketing Manager, MedGenome Inc

Traumatic brain injury (TBI) poses complex challenges for researchers aiming to understand cellular responses post-injury. Professor Michelle H. Theus of Virginia Tech partnered with MedGenome to shed light on the cellular dynamics underlying injury progression and recovery on a murine TBI model using single-cell and spatial transcriptomics.

Mapping Cellular Landscapes in TBI

Through spatial transcriptomics, MedGenome’s team mapped injured and uninjured brain regions, visualizing how specific cell populations—such as astrocytes and endothelial cells—adapt within the injury site. This spatial resolution allowed for a closer look at the blood-brain barrier’s breakdown and inflammatory processes in response to trauma.

Mapping Cellular Landscapes in TBI

Single-Cell Precision to Decode Cellular Response

Single-cell RNA sequencing enabled high-resolution analysis of gene expression across distinct cell types. For example, astrocytes showed specific gene expression changes crucial for understanding neuroinflammation and regeneration, while insights into endothelial cells provided clues about vascular repair.

Mice model comparison

When comparing two different mice models, gene KO model vs WT, spatial data allowed the identification of physiological and cellular changes within the injured area, including changes in astrocytes and endothelial cell population.

Spatial GEX in WT vs KO
Spatial GEX in WT vs KO
Endothelial cell population in KO vs WT
Endothelial cell population in KO vs WT
Astrocyte population in KO vs WT
Astrocyte population in KO vs WT
Spatial GEX combined to fluorescence microscopic images
Spatial GEX combined to fluorescence microscopic images

From Data to Insight

With MedGenome’s comprehensive bioinformatics suite, each dataset became a roadmap of molecular interactions and cellular pathways, offering valuable insights for drug discovery and therapeutic advancements.

“From the genomic data—from the transcriptomic data—we were able to validate signaling at the protein level and then test therapeutically in our animal model. So, we were in a fortunate position to go from early transcriptomics all the way to testing drug therapy.” — Michelle Theus, Virginia Tech

MedGenome’s expertise in multiomics and bioinformatics is enhancing neuroscience research. By combining single-cell and spatial technologies, we’re equipping researchers with the tools to untangle complex biological responses and advance brain injury therapeutics.

Contact us to learn how single-cell and spatial transcriptomics can support your research.

 

 
#spatial transcriptomics, #Traumatic brain injury, #astrocytes and endothelial cells, #gene expression, #single-cell RNA sequencing, #multiomics
 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *


For any suggestions or to know about the guidelines for submitting guest blog articles, please write to Vinay CG at
mgus-blog@medgenome.com

©2025 MedGenome | All rights reserved | Terms & conditions | Privacy policy
Request a quote